{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:47:09Z","timestamp":1794847629733,"version":"4.9.1"},"publisher-location":"Cham","reference-count":194,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032121653","type":"print"},{"value":"9783032121660","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-12166-0_2","type":"book-chapter","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:16:46Z","timestamp":1783768606000},"page":"43-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucose and Lactate, Starters or\u00a0Intermediates of Cancer Metabolic\u00a0Rewiring"],"prefix":"10.1007","author":[{"given":"Cindy","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1111\/BPH.15239","volume":"177","author":"AE Allen","year":"2020","unstructured":"Allen AE, Martin EA, Greenwood K et al (2020) Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat. Br J Pharmacol 177:4734. https:\/\/doi.org\/10.1111\/BPH.15239","journal-title":"Br J Pharmacol"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3390\/IJMS26051879","volume":"26","author":"W Andryszkiewicz","year":"2025","unstructured":"Andryszkiewicz W, G\u0105siorowska J, K\u00fcbler M et al (2025) Glucose metabolism and tumor microenvironment: mechanistic insights and therapeutic implications. Int J Mol Sci 26:1879. https:\/\/doi.org\/10.3390\/IJMS26051879","journal-title":"Int J Mol Sci"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-20-4190","volume":"81","author":"M Apostolidi","year":"2021","unstructured":"Apostolidi M, Vathiotis IA, Muthusamy V et al (2021) Targeting pyruvate kinase M2 phosphorylation reverses aggressive cancer phenotypes. Cancer Res 81:4346\u20134359. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-4190","journal-title":"Cancer Res"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.celrep.2014.11.025","volume":"9","author":"GH Baek","year":"2014","unstructured":"Baek GH, Tse YF, Hu Z et al (2014) MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. Cell Rep 9:2233\u20132249. https:\/\/doi.org\/10.1016\/j.celrep.2014.11.025","journal-title":"Cell Rep"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1016\/j.biocel.2009.08.012","volume":"41","author":"N Bellance","year":"2009","unstructured":"Bellance N, Benard G, Furt F et al (2009) Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566\u20132577. https:\/\/doi.org\/10.1016\/j.biocel.2009.08.012","journal-title":"Int J Biochem Cell Biol"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.GDE.2010.10.001","volume":"21","author":"MJ Berardi","year":"2011","unstructured":"Berardi MJ, Fantin VR (2011) Survival of the fittest: metabolic adaptations in cancer. Curr Opin Genet Dev 21:59\u201366. https:\/\/doi.org\/10.1016\/J.GDE.2010.10.001","journal-title":"Curr Opin Genet Dev"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ng.2471","volume":"45","author":"K Birsoy","year":"2013","unstructured":"Birsoy K, Wang T, Possemato R et al (2013) MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet 45:104\u2013108. https:\/\/doi.org\/10.1038\/ng.2471","journal-title":"Nat Genet"},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/cancers11020257","volume":"11","author":"R Bok","year":"2019","unstructured":"Bok R, Lee J, Sriram R et al (2019) The role of lactate metabolism in prostate cancer progression and metastases revealed by dual-agent hyperpolarized 13 C MRSI. Cancers 11:2. https:\/\/doi.org\/10.3390\/cancers11020257","journal-title":"Cancers"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/NCHEMBIO.2143","volume":"12","author":"A Boudreau","year":"2016","unstructured":"Boudreau A, Purkey HE, Hitz A et al (2016) Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition. Nat Chem Biol 12:779\u2013786. https:\/\/doi.org\/10.1038\/NCHEMBIO.2143","journal-title":"Nat Chem Biol"},{"key":"2_CR10","doi-asserted-by":"publisher","unstructured":"Brizel DM, Schroeder T, Scher RL et al (2001) Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys 51:349\u2013353. https:\/\/doi.org\/10.1016\/S0360-3016(01)01630-3","DOI":"10.1016\/S0360-3016(01)01630-3"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/J.CMET.2018.03.008","volume":"27","author":"GA Brooks","year":"2018","unstructured":"Brooks GA (2018) The science and translation of lactate shuttle theory. Cell Metab 27:757\u2013785. https:\/\/doi.org\/10.1016\/J.CMET.2018.03.008","journal-title":"Cell Metab"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/01.tp.0000287543.91765.41","volume":"84","author":"V Bueno","year":"2007","unstructured":"Bueno V, Binet I, Steger U et al (2007) The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse. Transplantation 84:1204\u20131207. https:\/\/doi.org\/10.1097\/01.tp.0000287543.91765.41","journal-title":"Transplantation"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","volume":"89","author":"AF Chambers","year":"1997","unstructured":"Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260\u20131270. https:\/\/doi.org\/10.1093\/jnci\/89.17.1260","journal-title":"J Natl Cancer Inst"},{"key":"2_CR14","doi-asserted-by":"publisher","unstructured":"Chan DA, Sutphin PD, Nguyen P et al (2011) Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med 3:1\u201317. https:\/\/doi.org\/10.1126\/SCITRANSLMED.3002394","DOI":"10.1126\/SCITRANSLMED.3002394"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nchembio.2172","volume":"12","author":"YJ Chen","year":"2016","unstructured":"Chen YJ, Mahieu NG, Huang X et al (2016) Lactate metabolism is associated with mammalian mitochondria. Nat Chem Biol 12:937\u2013943. https:\/\/doi.org\/10.1038\/nchembio.2172","journal-title":"Nat Chem Biol"},{"key":"2_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13485-8","volume":"10","author":"A Cheng","year":"2019","unstructured":"Cheng A, Zhang P, Wang B et al (2019) Aurora-A mediated phosphorylation of LDHB promotes glycolysis and tumor progression by relieving the substrate-inhibition effect. Nat Commun 10: 5566. https:\/\/doi.org\/10.1038\/s41467-019-13485-8","journal-title":"Nat Commun"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8730816","volume":"2019","author":"F Ciccarese","year":"2019","unstructured":"Ciccarese F, Zulato E, Indraccolo S (2019) LKB1\/AMPK pathway and drug response in cancer: a therapeutic perspective. Oxid Med Cell Longev 2019:1\u201316. https:\/\/doi.org\/10.1155\/2019\/8730816","journal-title":"Oxid Med Cell Longev"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL et al (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513:559\u2013563. https:\/\/doi.org\/10.1038\/nature13490","journal-title":"Nature"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"69219","DOI":"10.18632\/oncotarget.18215","volume":"8","author":"NJ Curtis","year":"2017","unstructured":"Curtis NJ, Mooney L, Hopcroft L et al (2017) Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt\u2019s lymphoma anti-tumor activity. Oncotarget 8:69219\u201369236. https:\/\/doi.org\/10.18632\/oncotarget.18215","journal-title":"Oncotarget"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"e46571","DOI":"10.1371\/journal.pone.0046571","volume":"7","author":"CJ de Saedeleer","year":"2012","unstructured":"de Saedeleer CJ, Copetti T, Porporato PE et al (2012) Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells. PLoS One 7:e46571. https:\/\/doi.org\/10.1371\/journal.pone.0046571","journal-title":"PLoS One"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1021\/jm980334n","volume":"41","author":"LM Deck","year":"1998","unstructured":"Deck LM, Royer RE, Chamblee BB et al (1998) Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum. J Med Chem 41:3879\u20133887. https:\/\/doi.org\/10.1021\/jm980334n","journal-title":"J Med Chem"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/J.CPT.2022.09.001","volume":"1","author":"H Deng","year":"2022","unstructured":"Deng H, Chen Y, Li P et al (2022) PI3K\/AKT\/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer. Cancer Pathog Ther 1:56\u201366. https:\/\/doi.org\/10.1016\/J.CPT.2022.09.001","journal-title":"Cancer Pathog Ther"},{"key":"2_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02733-4","volume":"9","author":"D DeWaal","year":"2018","unstructured":"DeWaal D, Nogueira V, Terry AR et al (2018) Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun 9:446. https:\/\/doi.org\/10.1038\/s41467-017-02733-4","journal-title":"Nat Commun"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1158\/2159-8290.CD-20-1211","volume":"11","author":"P Dey","year":"2021","unstructured":"Dey P, Kimmelman AC, Depinho RA (2021) Metabolic codependencies in the tumor microenvironment. Cancer Discov 11:1067\u20131081. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1211","journal-title":"Cancer Discov"},{"key":"2_CR25","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.2174\/138161212799504902","volume":"18","author":"S Dhup","year":"2012","unstructured":"Dhup S, Kumar Dadhich R, Ettore Porporato P, Sonveaux P (2012) Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 18:1319\u20131330. https:\/\/doi.org\/10.2174\/138161212799504902","journal-title":"Curr Pharm Des"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1358\/DOT.2003.39.3.799451","volume":"39","author":"S Di Cosimo","year":"2003","unstructured":"Di Cosimo S, Ferretti G, Papaldo P et al (2003) Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today 39:157\u2013173. https:\/\/doi.org\/10.1358\/DOT.2003.39.3.799451","journal-title":"Drugs Today"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"Doherty JR, Cleveland JL (2013) Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123:3685\u20133692. https:\/\/doi.org\/10.1172\/JCI69741","journal-title":"J Clin Invest"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/S10637-013-0047-4","volume":"32","author":"EM Dunbar","year":"2013","unstructured":"Dunbar EM, Coats BS, Shroads AL et al (2013) Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors. Invest New Drugs 32:452. https:\/\/doi.org\/10.1007\/S10637-013-0047-4","journal-title":"Invest New Drugs"},{"key":"2_CR29","doi-asserted-by":"publisher","unstructured":"Elmetwalli A, Kamosh NH, El Safty R et al (2024) Novel phloretin-based combinations targeting glucose metabolism in hepatocellular carcinoma through GLUT2\/PEPCK axis of action: in silico molecular modelling and in vivo studies. Med Oncol 41:1\u201319. https:\/\/doi.org\/10.1007\/S12032-023-02236-X","DOI":"10.1007\/S12032-023-02236-X"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","volume":"9","author":"VR Fantin","year":"2006","unstructured":"Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9:425\u2013434. https:\/\/doi.org\/10.1016\/j.ccr.2006.04.023","journal-title":"Cancer Cell"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","volume":"171","author":"B Faubert","year":"2017","unstructured":"Faubert B, Li KY, Cai L et al (2017) Lactate metabolism in human lung tumors. Cell 171:358\u2013371.e9. https:\/\/doi.org\/10.1016\/j.cell.2017.09.019","journal-title":"Cell"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2019.00547","volume":"9","author":"MLa Ferla","year":"2019","unstructured":"Ferla MLa, Lessi F, Aretini P et al (2019) ANKRd44 gene silencing: a putative role in trastuzumab resistance in HER2-like breast cancer. Front Oncol 9:1\u201315. https:\/\/doi.org\/10.3389\/fonc.2019.00547","journal-title":"Front Oncol"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S et al (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109:3812\u20133819. https:\/\/doi.org\/10.1182\/blood-2006-07-035972","journal-title":"Blood"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1124\/jpet.119.256503","volume":"370","author":"KE Follman","year":"2019","unstructured":"Follman KE, Morris ME (2019) Treatment of \u03b3-hydroxybutyric acid and \u03b3-butyrolactone overdose with two potent monocarboxylate transporter 1 inhibitors, AZD3965 and AR-C155858. J Pharmacol Exp Ther 370:84\u201391. https:\/\/doi.org\/10.1124\/jpet.119.256503","journal-title":"J Pharmacol Exp Ther"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0006-291X(03)00723-X","volume":"305","author":"B Formby","year":"2003","unstructured":"Formby B, Stern R (2003) Lactate-sensitive response elements in genes involved in hyaluronan catabolism. Biochem Biophys Res Commun 305:203\u2013208. https:\/\/doi.org\/10.1016\/S0006-291X(03)00723-X","journal-title":"Biochem Biophys Res Commun"},{"key":"2_CR36","first-page":"6020","volume":"61","author":"D Fukumura","year":"2001","unstructured":"Fukumura D, Xu L, Chen Y et al (2001) Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res 61:6020\u20136024","journal-title":"Cancer Res"},{"key":"2_CR37","first-page":"4909","volume":"29","author":"S Ganapathy-Kanniappan","year":"2009","unstructured":"Ganapathy-Kanniappan S, Geschwind JFH, Kunjithapatham R et al (2009) Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Res 29:4909","journal-title":"Anticancer Res"},{"key":"2_CR38","first-page":"5745","volume":"56","author":"RA Gatenby","year":"1996","unstructured":"Gatenby RA, Gawlinski ET (1996) A reaction-diffusion model of cancer invasion. Cancer Res 56:5745\u20135753","journal-title":"Cancer Res"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1158\/0008-5472.CAN-05-4193","volume":"66","author":"RA Gatenby","year":"2006","unstructured":"Gatenby RA, Gawlinski ET, Gmitro AF et al (2006) Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 66:5216\u20135223. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4193","journal-title":"Cancer Res"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3892\/ijo.2011.1055","volume":"39","author":"K Goetze","year":"2011","unstructured":"Goetze K, Walenta S, Ksiazkiewicz M et al (2011) Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol 39:453\u2013463. https:\/\/doi.org\/10.3892\/ijo.2011.1055","journal-title":"Int J Oncol"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1182\/blood-2005-05-1795","volume":"107","author":"E Gottfried","year":"2006","unstructured":"Gottfried E, Kunz-Schughart LA, Ebner S et al (2006) Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107:2013\u20132021. https:\/\/doi.org\/10.1182\/blood-2005-05-1795","journal-title":"Blood"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/NAR\/GKAD1193","volume":"52","author":"X Gu","year":"2024","unstructured":"Gu X, Zhuang A, Yu J et al (2024) Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A. Nucleic Acids Res 52:2273\u20132289. https:\/\/doi.org\/10.1093\/NAR\/GKAD1193","journal-title":"Nucleic Acids Res"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1021\/jm060995h","volume":"50","author":"SD Guile","year":"2007","unstructured":"Guile SD, Bantick JR, Cooper ME et al (2007) Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties. J Med Chem 50:254\u2013263. https:\/\/doi.org\/10.1021\/jm060995h","journal-title":"J Med Chem"},{"key":"2_CR44","doi-asserted-by":"publisher","unstructured":"Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 343:281\u2013299. https:\/\/doi.org\/10.1042\/0264-6021:3430281","DOI":"10.1042\/0264-6021:3430281"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2017.35.15_SUPPL.2516","volume":"35","author":"SER Halford","year":"2017","unstructured":"Halford SER, Jones P, Wedge S et al (2017) A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours. J Clin Oncol 35:2516\u20132516. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_SUPPL.2516","journal-title":"J Clin Oncol"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1096\/FJ.201902961R","volume":"34","author":"JYS Han","year":"2020","unstructured":"Han JYS, Kinoshita J, Bisetto S et al (2020) Role of monocarboxylate transporters in regulating metabolic homeostasis in the outer retina: insight gained from cell-specific Bsg deletion. FASEB J 34:5401. https:\/\/doi.org\/10.1096\/FJ.201902961R","journal-title":"FASEB J"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24619-2","volume":"12","author":"J He","year":"2021","unstructured":"He J, Shangguan X, Zhou W et al (2021) Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. Nat Commun 12:1\u201314. https:\/\/doi.org\/10.1038\/s41467-021-24619-2","journal-title":"Nat Commun"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley CT, Faubert B, Yuan Q et al (2016) Metabolic heterogeneity in human lung tumors. Cell 164:681\u2013694. https:\/\/doi.org\/10.1016\/j.cell.2015.12.034","journal-title":"Cell"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-3-030-34025-4_16","volume":"1219","author":"A Hip\u00f3lito","year":"2020","unstructured":"Hip\u00f3lito A, Mendes C, Serpa J (2020) The metabolic remodelling in lung cancer and its putative consequence in therapy response. Adv Exp Med Biol 1219:311\u2013333. https:\/\/doi.org\/10.1007\/978-3-030-34025-4_16","journal-title":"Adv Exp Med Biol"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","volume":"71","author":"F Hirschhaeuser","year":"2011","unstructured":"Hirschhaeuser F, Sattler UGA, Mueller-Klieser W (2011) Lactate: a metabolic key player in cancer. Cancer Res 71:6921\u20136925. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1457","journal-title":"Cancer Res"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1074\/jbc.RA118.006095","volume":"294","author":"SM Hong","year":"2019","unstructured":"Hong SM, Lee YK, Park I et al (2019) Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis. J Biol Chem 294:7810\u20137820. https:\/\/doi.org\/10.1074\/jbc.RA118.006095","journal-title":"J Biol Chem"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/S41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD (2020) The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer 20:74\u201388. https:\/\/doi.org\/10.1038\/S41568-019-0216-7","journal-title":"Nat Rev Cancer"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.3390\/CANCERS12113332","volume":"12","author":"Y Huang","year":"2020","unstructured":"Huang Y, Sun G, Sun X et al (2020) The potential of lonidamine in combination with chemotherapy and physical therapy in cancer treatment. Cancers 12:3332. https:\/\/doi.org\/10.3390\/CANCERS12113332","journal-title":"Cancers"},{"key":"2_CR54","doi-asserted-by":"publisher","unstructured":"Huang ZW, Zhang XN, Zhang L et al (2023) STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther 8:1\u201313. https:\/\/doi.org\/10.1038\/S41392-023-01605-2","DOI":"10.1038\/S41392-023-01605-2"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature24057","volume":"551","author":"S Hui","year":"2017","unstructured":"Hui S, Ghergurovich JM, Morscher RJ et al (2017) Glucose feeds the TCA cycle via circulating lactate. Nature 551:115\u2013118. https:\/\/doi.org\/10.1038\/nature24057","journal-title":"Nature"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"e3934","DOI":"10.1002\/CBF.3934","volume":"42","author":"H Huldani","year":"2024","unstructured":"Huldani H, Malviya J, Rodrigues P et al (2024) Discovering the strength of immunometabolism in cancer therapy: Employing metabolic pathways to enhance immune responses. Cell Biochem Funct 42:e3934. https:\/\/doi.org\/10.1002\/CBF.3934","journal-title":"Cell Biochem Funct"},{"key":"2_CR57","doi-asserted-by":"crossref","unstructured":"Hunt TK, Aslam R, Hussain Z, Beckert S (2008) Lactate, with oxygen, incites angiogenesis. Adv Exper Med Biol 614:73-80","DOI":"10.1007\/978-0-387-74911-2_9"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","volume":"191","author":"Z Husain","year":"2013","unstructured":"Husain Z, Huang Y, Seth P, Sukhatme VP (2013) Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK Cells. J Immunol 191:1486\u20131495. https:\/\/doi.org\/10.4049\/jimmunol.1202702","journal-title":"J Immunol"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1152\/physiolgenomics.00177.2010","volume":"43","author":"R Hussien","year":"2011","unstructured":"Hussien R, Brooks GA (2011) Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiol Genomics 43:255\u2013264. https:\/\/doi.org\/10.1152\/physiolgenomics.00177.2010","journal-title":"Physiol Genomics"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1349-7006.2011.01908.x","volume":"102","author":"H Izumi","year":"2011","unstructured":"Izumi H, Takahashi M, Uramoto H et al (2011) Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 102:1007\u20131013. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01908.x","journal-title":"Cancer Sci"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0009-8981(88)90359-2","volume":"173","author":"T Kanno","year":"1988","unstructured":"Kanno T, Sudo K, Maekawa M et al (1988) Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy. Clin Chim Acta 173:89\u201398. https:\/\/doi.org\/10.1016\/0009-8981(88)90359-2","journal-title":"Clin Chim Acta"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"e75154","DOI":"10.1371\/journal.pone.0075154","volume":"8","author":"KM Kennedy","year":"2013","unstructured":"Kennedy KM, Scarbrough PM, Ribeiro A et al (2013) Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. PLoS One 8:e75154. https:\/\/doi.org\/10.1371\/journal.pone.0075154","journal-title":"PLoS One"},{"key":"2_CR63","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.1128\/MCB.00440-07","volume":"27","author":"J Kim","year":"2007","unstructured":"Kim J, Gao P, Liu Y-C et al (2007) Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 27:7381\u20137393. https:\/\/doi.org\/10.1128\/MCB.00440-07","journal-title":"Mol Cell Biol"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1093\/emboj\/19.15.3896","volume":"19","author":"P Kirk","year":"2000","unstructured":"Kirk P, Wilson MC, Heddle C et al (2000) CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 19:3896\u20133904. https:\/\/doi.org\/10.1093\/emboj\/19.15.3896","journal-title":"EMBO J"},{"key":"2_CR65","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/JNCI\/21.3.485","volume":"21","author":"BR Landau","year":"1958","unstructured":"Landau BR, Laszlo J, Stengle J, Burk D (1958) Certain metabolic and pharmacologic effects in cancer patients given infusions of 2-deoxy-D-glucose. J Natl Cancer Inst 21:485\u2013494. https:\/\/doi.org\/10.1093\/JNCI\/21.3.485","journal-title":"J Natl Cancer Inst"},{"key":"2_CR66","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature04808","volume":"442","author":"JL Langowski","year":"2006","unstructured":"Langowski JL, Zhang X, Wu L et al (2006) IL-23 promotes tumour incidence and growth. Nature 442:461\u2013465. https:\/\/doi.org\/10.1038\/nature04808","journal-title":"Nature"},{"key":"2_CR67","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1189\/jlb.69.4.522","volume":"69","author":"A Lardner","year":"2001","unstructured":"Lardner A (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69:522\u2013530. https:\/\/doi.org\/10.1189\/jlb.69.4.522","journal-title":"J Leukoc Biol"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1124\/DMD.123.001430","volume":"52","author":"BD Latham","year":"2024","unstructured":"Latham BD, Geffert RM, Jackson KD (2024) Kinase inhibitors FDA approved 2018-2023: drug targets, metabolic pathways, and drug-induced toxicities. Drug Metab Dispos 52:479\u2013492. https:\/\/doi.org\/10.1124\/DMD.123.001430","journal-title":"Drug Metab Dispos"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2015.03.011","volume":"161","author":"DC Lee","year":"2015","unstructured":"Lee DC, Sohn HA, Park ZY et al (2015) A lactate-induced response to hypoxia. Cell 161:595\u2013609. https:\/\/doi.org\/10.1016\/j.cell.2015.03.011","journal-title":"Cell"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee Y, Morrison BM, Li Y et al (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443\u2013448. https:\/\/doi.org\/10.1038\/nature11314","journal-title":"Nature"},{"key":"2_CR71","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/onc.2014.47","volume":"34","author":"K Leithner","year":"2015","unstructured":"Leithner K, Hrzenjak A, Tr\u00f6tzm\u00fcller M et al (2015) PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Oncogene 34:1044\u20131050. https:\/\/doi.org\/10.1038\/onc.2014.47","journal-title":"Oncogene"},{"key":"2_CR72","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.7314\/APJCP.2013.14.7.4107","volume":"14","author":"LN Li","year":"2013","unstructured":"Li LN, Zhou X, Gu Y, Yan J (2013) Prognostic value of MMP-9 in ovarian cancer: a meta-analysis. Asian Pac J Cancer Prev 14:4107\u20134113. https:\/\/doi.org\/10.7314\/APJCP.2013.14.7.4107","journal-title":"Asian Pac J Cancer Prev"},{"key":"2_CR73","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.3892\/ol.2017.6924","volume":"14","author":"H Li","year":"2017","unstructured":"Li H, Qiu Z, Li F, Wang C (2017) The relationship between MMP-2 and MMP-9 expression levels with breast cancer incidence and prognosis. Oncol Lett 14:5865\u20135870. https:\/\/doi.org\/10.3892\/ol.2017.6924","journal-title":"Oncol Lett"},{"key":"2_CR74","doi-asserted-by":"publisher","unstructured":"Li F, Zhang H, Huang Y et al (2024a) Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat 73:1\u201313. https:\/\/doi.org\/10.1016\/J.DRUP.2024.101059","DOI":"10.1016\/J.DRUP.2024.101059"},{"key":"2_CR75","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L et al (2024b) Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy 20:1--14. https:\/\/doi.org\/10.1080\/15548627.2023.2249762","journal-title":"Autophagy"},{"key":"2_CR76","doi-asserted-by":"publisher","first-page":"113688","DOI":"10.1016\/J.CELREP.2024.113688","volume":"43","author":"XM Li","year":"2024","unstructured":"Li XM, Yang Y, Jiang FQ et al (2024c) Histone lactylation inhibits RAR\u03b3 expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling. Cell Rep 43:113688. https:\/\/doi.org\/10.1016\/J.CELREP.2024.113688","journal-title":"Cell Rep"},{"key":"2_CR77","doi-asserted-by":"publisher","unstructured":"Li Y, Song Y, Shi Z et al (2024d) Syrosingopine and UK5099 synergistically suppress non-small cell lung cancer by activating the integrated stress response. Cell Death Dis 15:1-14. https:\/\/doi.org\/10.1038\/S41419-024-06821-4","DOI":"10.1038\/S41419-024-06821-4"},{"key":"2_CR78","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells?. Trends Biochem Sci 41:211\u2013218. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001","journal-title":"Trends Biochem Sci"},{"key":"2_CR79","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/S40170-021-00263-8","volume":"9","author":"DF Liefwalker","year":"2021","unstructured":"Liefwalker DF, Ryan M, Wang Z et al (2021) Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies. Cancer Metab 9:31. https:\/\/doi.org\/10.1186\/S40170-021-00263-8","journal-title":"Cancer Metab"},{"key":"2_CR80","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-08-2985","volume":"15","author":"G Liu","year":"2009","unstructured":"Liu G, Kelly WK, Wilding G et al (2009) An open-label, multicenter, phase I\/II study of single-agent AT-101 in men with castrate-resistant prostate cancer. Clin Cancer Res 15:3172\u20133176. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2985","journal-title":"Clin Cancer Res"},{"key":"2_CR81","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.3892\/ijo.2017.3979","volume":"50","author":"Y Liu","year":"2017","unstructured":"Liu Y, Murray-Stewart T, Casero RA et al (2017) Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth. Int J Oncol 50:2011\u20132023. https:\/\/doi.org\/10.3892\/ijo.2017.3979","journal-title":"Int J Oncol"},{"key":"2_CR82","doi-asserted-by":"publisher","first-page":"101042831875620","DOI":"10.1177\/1010428318756203","volume":"40","author":"F Lopes-Coelho","year":"2018","unstructured":"Lopes-Coelho F, Gouveia-Fernandes S, Serpa J (2018) Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression. Tumor Biol 40:101042831875620. https:\/\/doi.org\/10.1177\/1010428318756203","journal-title":"Tumor Biol"},{"key":"2_CR83","doi-asserted-by":"publisher","first-page":"82803","DOI":"10.18632\/oncotarget.20294","volume":"8","author":"F Lopes-Coelho","year":"2017","unstructured":"Lopes-Coelho F, Nunes C, Gouveia-Fernandes S et al (2017) Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells. Oncotarget 8:82803\u201382823. https:\/\/doi.org\/10.18632\/oncotarget.20294","journal-title":"Oncotarget"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.ijbiomac.2022.10.014","volume":"222","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yang Z, Yu Y, Zhang P (2022) HIF1\u03b1 lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. Int J Biol Macromol 222:2225\u20132243. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.10.014","journal-title":"Int J Biol Macromol"},{"key":"2_CR85","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/0006-291X(90)92374-9","volume":"168","author":"M Maekawa","year":"1990","unstructured":"Maekawa M, Sudo K, Kanno T, Li SSL (1990) Molecular characterization of genetic mutation in human lactate dehydrogenase-A (M) deficiency. Biochem Biophys Res Commun 168:677\u2013682. https:\/\/doi.org\/10.1016\/0006-291X(90)92374-9","journal-title":"Biochem Biophys Res Commun"},{"key":"2_CR86","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/01.RES.56.6.773","volume":"56","author":"RL Mahnensmith","year":"1985","unstructured":"Mahnensmith RL, Aronson PS (1985) The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes. Circ Res 56:773\u2013788. https:\/\/doi.org\/10.1161\/01.RES.56.6.773","journal-title":"Circ Res"},{"key":"2_CR87","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cmdc.201100471","volume":"7","author":"M Manerba","year":"2012","unstructured":"Manerba M, Vettraino M, Fiume L et al (2012) Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase. ChemMedChem 7:311\u2013317. https:\/\/doi.org\/10.1002\/cmdc.201100471","journal-title":"ChemMedChem"},{"key":"2_CR88","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/J.NEO.2020.12.009","volume":"23","author":"F Marcucci","year":"2021","unstructured":"Marcucci F, Rumio C (2021) Glycolysis-induced drug resistance in tumors-A response to danger signals? Neoplasia 23:234\u2013245. https:\/\/doi.org\/10.1016\/J.NEO.2020.12.009","journal-title":"Neoplasia"},{"key":"2_CR89","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3389\/fonc.2013.00199","volume":"3","author":"T Matsubara","year":"2013","unstructured":"Matsubara T, DiResta GR, Kakunaga S et al (2013) Additive influence of extracellular pH, oxygen tension, and pressure on invasiveness and survival of human osteosarcoma cells. Front Oncol 3:199. https:\/\/doi.org\/10.3389\/fonc.2013.00199","journal-title":"Front Oncol"},{"key":"2_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2023.107283","volume":"182","author":"C Mendes","year":"2023","unstructured":"Mendes C, Lemos I, Francisco I et al (2023) NSCLC presents metabolic heterogeneity, and there is still some leeway for EGF stimuli in EGFR-mutated NSCLC. Lung Cancer 182:1\u201321. https:\/\/doi.org\/10.1016\/j.lungcan.2023.107283","journal-title":"Lung Cancer"},{"key":"2_CR91","doi-asserted-by":"publisher","first-page":"BSR20240752","DOI":"10.1042\/BSR20240752","volume":"44","author":"C Mendes","year":"2024","unstructured":"Mendes C, Lemos I, Hip\u00f3lito A et al (2024) Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells. Biosci Rep 44:BSR20240752. https:\/\/doi.org\/10.1042\/BSR20240752","journal-title":"Biosci Rep"},{"key":"2_CR92","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00109-020-01965-0","volume":"98","author":"C Mendes","year":"2020","unstructured":"Mendes C, Serpa J (2020) Revisiting lactate dynamics in cancer\u2014a metabolic expertise or an alternative attempt to survive? J Mol Med 98:1397\u20131414. https:\/\/doi.org\/10.1007\/s00109-020-01965-0","journal-title":"J Mol Med"},{"key":"2_CR93","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ijc.26410","volume":"131","author":"AN Mendler","year":"2012","unstructured":"Mendler AN, Hu B, Prinz PU et al (2012) Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation. Int J Cancer 131:633\u2013640. https:\/\/doi.org\/10.1002\/ijc.26410","journal-title":"Int J Cancer"},{"key":"2_CR94","doi-asserted-by":"publisher","unstructured":"Meng Q, Sun H, Zhang Y et al (2024) Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression. J Exper Clin Cancer Res 43:1\u201319. https:\/\/doi.org\/10.1186\/S13046-024-02943-X","DOI":"10.1186\/S13046-024-02943-X"},{"key":"2_CR95","doi-asserted-by":"publisher","first-page":"e2010075118","DOI":"10.1073\/PNAS.2010075118","volume":"118","author":"M Mojica-Benavides","year":"2021","unstructured":"Mojica-Benavides M, van Niekerk DD, Mijalkov M et al (2021) Intercellular communication induces glycolytic synchronization waves between individually oscillating cells. Proc Natl Acad Sci U S A 118:e2010075118. https:\/\/doi.org\/10.1073\/PNAS.2010075118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR96","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40170-019-0199-6","volume":"7","author":"ED Montal","year":"2019","unstructured":"Montal ED, Bhalla K, Dewi RE et al (2019) Inhibition of phosphoenolpyruvate carboxykinase blocks lactate utilization and impairs tumor growth in colorectal cancer. Cancer Metab 7:8. https:\/\/doi.org\/10.1186\/s40170-019-0199-6","journal-title":"Cancer Metab"},{"key":"2_CR97","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","volume":"17","author":"X Mu","year":"2018","unstructured":"Mu X, Shi W, Xu Y et al (2018) Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer. Cell Cycle 17:428\u2013438. https:\/\/doi.org\/10.1080\/15384101.2018.1444305","journal-title":"Cell Cycle"},{"key":"2_CR98","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/S41423-022-00894-X","volume":"19","author":"X Mu","year":"2022","unstructured":"Mu X, Xiang Z, Xu Y et al (2022) Glucose metabolism controls human \u03b3\u03b4 T-cell-mediated tumor immunosurveillance in diabetes. Cell Mol Immunol 19:944\u2013956. https:\/\/doi.org\/10.1038\/S41423-022-00894-X","journal-title":"Cell Mol Immunol"},{"key":"2_CR99","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/S12185-012-1070-5","volume":"95","author":"V Mucaj","year":"2012","unstructured":"Mucaj V, Shay JES, Simon MC (2012) Effects of hypoxia and HIFs on cancer metabolism. Int J Hematol 95:464\u2013470. https:\/\/doi.org\/10.1007\/S12185-012-1070-5","journal-title":"Int J Hematol"},{"key":"2_CR100","doi-asserted-by":"publisher","unstructured":"Muscella A, Vetrugno C, Cossa LG, Marsigliante S (2019) TGF-\u03b21 activates RSC96 Schwann cells migration and invasion through MMP-2 and MMP-9 activities. J\u00a0Neurochem 153:525-538. https:\/\/doi.org\/10.1111\/jnc.14913","DOI":"10.1111\/jnc.14913"},{"key":"2_CR101","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1134\/S0006297915020017","volume":"80","author":"DS Novikova","year":"2015","unstructured":"Novikova DS, Garabadzhiu AV, Melino G et al (2015) AMP-activated protein kinase: structure, function, and role in pathological processes. Biochemistry 80:127\u2013144. https:\/\/doi.org\/10.1134\/S0006297915020017","journal-title":"Biochemistry"},{"key":"2_CR102","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/CANCERS16071384","volume":"16","author":"S Orlovskiy","year":"2024","unstructured":"Orlovskiy S, Gupta PK, Roman J et al (2024) Lonidamine induced selective acidification and de-energization of prostate cancer xenografts: enhanced tumor response to radiation therapy. Cancers 16:1384. https:\/\/doi.org\/10.3390\/CANCERS16071384","journal-title":"Cancers"},{"key":"2_CR103","doi-asserted-by":"publisher","unstructured":"Oshima N, Ishida R, Kishimoto S et al (2020) Dynamic imaging of LDH inhibition in tumors reveals rapid in vivo metabolic rewiring and vulnerability to combination therapy. Cell Rep 30:1798\u20131810. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.039","DOI":"10.1016\/j.celrep.2020.01.039"},{"key":"2_CR104","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1016\/J.MOLCEL.2021.08.031","volume":"81","author":"C Pan","year":"2021","unstructured":"Pan C, Li B, Simon MC (2021) Moonlighting functions of metabolic enzymes and metabolites in cancer. Mol Cell 81:3760\u20133774. https:\/\/doi.org\/10.1016\/J.MOLCEL.2021.08.031","journal-title":"Mol Cell"},{"key":"2_CR105","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.celrep.2016.03.026","volume":"15","author":"S Park","year":"2016","unstructured":"Park S, Chang CY, Safi R et al (2016) ERR\u03b1-regulated lactate metabolism contributes to resistance to targeted therapies in breast cancer. Cell Rep 15:323\u2013335. https:\/\/doi.org\/10.1016\/j.celrep.2016.03.026","journal-title":"Cell Rep"},{"key":"2_CR106","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/J.CCR.2013.06.014","volume":"24","author":"KC Patra","year":"2013","unstructured":"Patra KC, Wang Q, Bhaskar PT et al (2013) Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell 24:213\u2013228. https:\/\/doi.org\/10.1016\/J.CCR.2013.06.014","journal-title":"Cancer Cell"},{"key":"2_CR107","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","volume":"8","author":"S Pavlides","year":"2009","unstructured":"Pavlides S, Whitaker-Menezes D, Castello-Cros R et al (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8:3984\u20134001. https:\/\/doi.org\/10.4161\/cc.8.23.10238","journal-title":"Cell Cycle"},{"key":"2_CR108","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2020","unstructured":"Payen VL, Mina E, Van H\u00e9e VF et al (2020) Monocarboxylate transporters in cancer. Mol Metab 33:48\u201366. https:\/\/doi.org\/10.1016\/j.molmet.2019.07.006","journal-title":"Mol Metab"},{"key":"2_CR109","doi-asserted-by":"publisher","first-page":"221","DOI":"10.21037\/atm.2019.01.85","volume":"7","author":"Z Pennington","year":"2019","unstructured":"Pennington Z, Goodwin ML, Westbroek EM et al (2019) Lactate and cancer: spinal metastases and potential therapeutic targets (part 2). Ann Transl Med 7:221. https:\/\/doi.org\/10.21037\/atm.2019.01.85","journal-title":"Ann Transl Med"},{"key":"2_CR110","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/15384101.2015.1120930","volume":"15","author":"J P\u00e9rez-Escuredo","year":"2016","unstructured":"P\u00e9rez-Escuredo J, Dadhich RK, Dhup S et al (2016) Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle 15:72\u201383. https:\/\/doi.org\/10.1080\/15384101.2015.1120930","journal-title":"Cell Cycle"},{"key":"2_CR111","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/joim.12016","volume":"273","author":"F Polet","year":"2013","unstructured":"Polet F, Feron O (2013) Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. J Intern Med 273:156\u2013165. https:\/\/doi.org\/10.1111\/joim.12016","journal-title":"J Intern Med"},{"key":"2_CR112","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1189\/jlb.0902451","volume":"73","author":"A Puig-Kr\u00f6ger","year":"2003","unstructured":"Puig-Kr\u00f6ger A, Mu\u00f1iz-Pello O, Selgas R et al (2003) Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucose-degradation products. J Leukoc Biol 73:482\u2013492. https:\/\/doi.org\/10.1189\/jlb.0902451","journal-title":"J Leukoc Biol"},{"key":"2_CR113","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/S42255-023-00800-3","volume":"5","author":"L Ran","year":"2023","unstructured":"Ran L, Zhang S, Wang G et al (2023) Mitochondrial pyruvate carrier-mediated metabolism is dispensable for the classical activation of macrophages. Nat Metab 5:804\u2013820. https:\/\/doi.org\/10.1038\/S42255-023-00800-3","journal-title":"Nat Metab"},{"key":"2_CR114","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/J.CHEMBIOL.2019.06.005","volume":"26","author":"ES Reckzeh","year":"2019","unstructured":"Reckzeh ES, Karageorgis G, Schwalfenberg M et al (2019) Inhibition of glucose transporters and glutaminase synergistically impairs tumor cell growth. Cell Chem Biol 26:1214\u20131228.e25. https:\/\/doi.org\/10.1016\/J.CHEMBIOL.2019.06.005","journal-title":"Cell Chem Biol"},{"key":"2_CR115","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/PH15020144","volume":"15","author":"O Renner","year":"2022","unstructured":"Renner O, Mayer M, Leischner C et al (2022) Systematic review of Gossypol\/AT-101 in cancer clinical trials. Pharmaceuticals 15:144. https:\/\/doi.org\/10.3390\/PH15020144","journal-title":"Pharmaceuticals"},{"key":"2_CR116","doi-asserted-by":"publisher","unstructured":"Richiardone E, Al Roumi R, Lardinois F et al (2024) MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy. Cancer Lett 598:1\u201313. https:\/\/doi.org\/10.1016\/j.canlet.2024.217091","DOI":"10.1016\/j.canlet.2024.217091"},{"key":"2_CR117","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.biocel.2010.07.010","volume":"42","author":"S Rodr\u00edguez-Enr\u00edquez","year":"2010","unstructured":"Rodr\u00edguez-Enr\u00edquez S, Carre\u00f1o-Fuentes L, Gallardo-P\u00e9rez JC et al (2010) Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma. Int J Biochem Cell Biol 42:1744\u20131751. https:\/\/doi.org\/10.1016\/j.biocel.2010.07.010","journal-title":"Int J Biochem Cell Biol"},{"key":"2_CR118","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1158\/0008-5472.CAN-14-0319","volume":"74","author":"CL Roland","year":"2014","unstructured":"Roland CL, Arumugam T, Deng D et al (2014) Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res 74:5301\u20135310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0319","journal-title":"Cancer Res"},{"key":"2_CR119","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fimmu.2016.00052","volume":"7","author":"S Romero-Garcia","year":"2016","unstructured":"Romero-Garcia S, Moreno-Altamirano MMB, Prado-Garcia H, S\u00e1nchez-Garc\u00eda FJ (2016) Lactate contribution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevance. Front Immunol 7:52. https:\/\/doi.org\/10.3389\/fimmu.2016.00052","journal-title":"Front Immunol"},{"key":"2_CR120","first-page":"6517","volume":"54","author":"J Rozhin","year":"1994","unstructured":"Rozhin J, Sameni M, Ziegler G, Sloane BF (1994) Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 54:6517\u20136525","journal-title":"Cancer Res"},{"key":"2_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12885-022-09211-1","volume":"22","author":"M Sadria","year":"2022","unstructured":"Sadria M, Seo D, Layton AT (2022) The mixed blessing of AMPK signaling in cancer treatments. BMC Cancer 22:1\u201316. https:\/\/doi.org\/10.1186\/S12885-022-09211-1","journal-title":"BMC Cancer"},{"key":"2_CR122","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cmet.2018.10.011","volume":"28","author":"SM Sanderson","year":"2018","unstructured":"Sanderson SM, Locasale JW (2018) Revisiting the Warburg effect: some tumors hold their breath. Cell Metab 28:669\u2013670. https:\/\/doi.org\/10.1016\/j.cmet.2018.10.011","journal-title":"Cell Metab"},{"key":"2_CR123","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/carcin\/bgw127","volume":"38","author":"I San-Mill\u00e1n","year":"2017","unstructured":"San-Mill\u00e1n I, Brooks GA (2017) Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect. Carcinogenesis 38:119\u2013133. https:\/\/doi.org\/10.1093\/carcin\/bgw127","journal-title":"Carcinogenesis"},{"key":"2_CR124","doi-asserted-by":"publisher","first-page":"621458","DOI":"10.3389\/FONC.2020.621458","volume":"10","author":"E Saulle","year":"2021","unstructured":"Saulle E, Spinello I, Quaranta MT et al (2021) Targeting lactate metabolism by inhibiting MCT1 or MCT4 impairs leukemic cell proliferation, induces two different related death-pathways and increases chemotherapeutic sensitivity of acute myeloid leukemia cells. Front Oncol 10:621458. https:\/\/doi.org\/10.3389\/FONC.2020.621458","journal-title":"Front Oncol"},{"key":"2_CR125","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/CELLS10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro C, Firestein BL (2021) Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells 10:1056. https:\/\/doi.org\/10.3390\/CELLS10051056","journal-title":"Cells"},{"key":"2_CR126","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1700\/1361.15105","volume":"99","author":"D Schveigert","year":"2013","unstructured":"Schveigert D, Valuckas KP, Kovalcis V et al (2013) Significance of MMP-9 expression and MMP-9 polymorphism in prostate cancer. Tumori 99:523\u2013529. https:\/\/doi.org\/10.1700\/1361.15105","journal-title":"Tumori"},{"key":"2_CR127","first-page":"4757","volume":"55","author":"G Schwickert","year":"1995","unstructured":"Schwickert G, Walenta S, Mueller-Klieser W et al (1995) Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 55:4757\u20134759","journal-title":"Cancer Res"},{"key":"2_CR128","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1158\/1055-9965.EPI-22-1133","volume":"32","author":"E Sedeta","year":"2023","unstructured":"Sedeta E, Sung H, Laversanne M et al (2023) Recent mortality patterns and time trends for the major cancers in 47 countries worldwide. Cancer Epidemiol Biomarkers Prev 32:894\u2013905","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2_CR129","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1172\/JCI37373","volume":"118","author":"GL Semenza","year":"2008","unstructured":"Semenza GL (2008) Tumor metabolism: cancer cells give and take lactate. J Clin Invest 118:3835\u20133837. https:\/\/doi.org\/10.1172\/JCI37373","journal-title":"J Clin Invest"},{"key":"2_CR130","doi-asserted-by":"publisher","unstructured":"Serpa J (2020) Metabolic remodeling as a way of adapting to tumor microenvironment (TME), a Job of several holders. Adv Exp Med Biol 1219:1\u201334. https:\/\/doi.org\/10.1007\/978-3-030-34025-4_1","DOI":"10.1007\/978-3-030-34025-4_1"},{"key":"2_CR131","doi-asserted-by":"publisher","unstructured":"Shibata S, Sogabe S, Miwa M et al (2021) Identification of the first highly selective inhibitor of human lactate dehydrogenase B. Sci Rep 11:1\u201312. https:\/\/doi.org\/10.1038\/S41598-021-00820-7","DOI":"10.1038\/S41598-021-00820-7"},{"key":"2_CR132","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.4049\/jimmunol.180.11.7175","volume":"180","author":"H Shime","year":"2008","unstructured":"Shime H, Yabu M, Akazawa T et al (2008) Tumor-secreted lactic acid promotes IL-23\/IL-17 proinflammatory pathway. J Immunol 180:7175\u20137183. https:\/\/doi.org\/10.4049\/jimmunol.180.11.7175","journal-title":"J Immunol"},{"key":"2_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41598-019-55296-3","volume":"9","author":"R Shiratori","year":"2019","unstructured":"Shiratori R, Furuichi K, Yamaguchi M et al (2019) Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner. Sci Rep 9:1\u201315. https:\/\/doi.org\/10.1038\/S41598-019-55296-3","journal-title":"Sci Rep"},{"key":"2_CR134","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/CMDC.201600276","volume":"11","author":"H Siebeneicher","year":"2016","unstructured":"Siebeneicher H, Cleve A, Rehwinkel H et al (2016) Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876. ChemMedChem 11:2261\u20132271. https:\/\/doi.org\/10.1002\/CMDC.201600276","journal-title":"ChemMedChem"},{"key":"2_CR135","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1007\/s13277-015-4385-z","volume":"37","author":"LS Silva","year":"2016","unstructured":"Silva LS, Goncalves LG, Silva F et al (2016) STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment. Tumor Biol 37:5385\u20135395. https:\/\/doi.org\/10.1007\/s13277-015-4385-z","journal-title":"Tumor Biol"},{"key":"2_CR136","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jtbi.2006.09.010","volume":"244","author":"K Smallbone","year":"2007","unstructured":"Smallbone K, Gatenby RA, Gillies RJ et al (2007) Metabolic changes during carcinogenesis: Potential impact on invasiveness. J Theor Biol 244:703\u2013713. https:\/\/doi.org\/10.1016\/j.jtbi.2006.09.010","journal-title":"J Theor Biol"},{"key":"2_CR137","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10863-009-9267-x","volume":"42","author":"K Smolkov\u00e1","year":"2010","unstructured":"Smolkov\u00e1 K, Bellance N, Scandurra F et al (2010) Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. J Bioenerg Biomembr 42:55\u201367. https:\/\/doi.org\/10.1007\/s10863-009-9267-x","journal-title":"J Bioenerg Biomembr"},{"key":"2_CR138","doi-asserted-by":"publisher","first-page":"e33418","DOI":"10.1371\/journal.pone.0033418","volume":"7","author":"P Sonveaux","year":"2012","unstructured":"Sonveaux P, Copetti T, de Saedeleer CJ et al (2012) Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS One 7:e33418. https:\/\/doi.org\/10.1371\/journal.pone.0033418","journal-title":"PLoS One"},{"key":"2_CR139","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1172\/JCI36843","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"Sonveaux P, V\u00e9gran F, Schroeder T et al (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930\u20133942. https:\/\/doi.org\/10.1172\/JCI36843","journal-title":"J Clin Invest"},{"key":"2_CR140","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2967\/jnumed.115.158808","volume":"57","author":"C Spick","year":"2016","unstructured":"Spick C, Herrmann K, Czernin J (2016) 18F-FDG PET\/CT and PET\/MRI perform equally well in cancer: Evidence from studies on more than 2,300 patients. J Nucl Med 57:420\u2013430. https:\/\/doi.org\/10.2967\/jnumed.115.158808","journal-title":"J Nucl Med"},{"key":"2_CR141","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1158\/2159-8290.CD-22-0805\/3283571\/CD-22-0805.PDF","volume":"13","author":"BD Stein","year":"2023","unstructured":"Stein BD, Ferrarone JR, Gardner EE et al (2023) LKB1-dependent regulation of TPI1 creates a divergent metabolic liability between human and mouse lung adenocarcinoma. Cancer Discov 13:1002\u20131025. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0805\/3283571\/CD-22-0805.PDF","journal-title":"Cancer Discov"},{"key":"2_CR142","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/B978-012374178-3.10012-2","volume":"18","author":"R Stern","year":"2008","unstructured":"Stern R (2008) Hyaluronidases in cancer biology. Hyaluronan Cancer Biol 18:275\u2013280. https:\/\/doi.org\/10.1016\/B978-012374178-3.10012-2","journal-title":"Hyaluronan Cancer Biol"},{"key":"2_CR143","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV (2022) Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov 21:141\u2013162. https:\/\/doi.org\/10.1038\/s41573-021-00339-6","journal-title":"Nat Rev Drug Discov"},{"key":"2_CR144","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/JTO.0b013e3181e8f4dc","volume":"5","author":"R Suk Heist","year":"2010","unstructured":"Suk Heist R, Fain J, Chinnasami B et al (2010) Phase I\/II study of AT-101 with topotecan in relapsed and refractory small cell lung cancer. J Thorac Oncol 5:1637\u20131643. https:\/\/doi.org\/10.1097\/JTO.0b013e3181e8f4dc","journal-title":"J Thorac Oncol"},{"key":"2_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B et al (2023) Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer. Nat Commun 14:1\u201316. https:\/\/doi.org\/10.1038\/s41467-023-42025-8","journal-title":"Nat Commun"},{"key":"2_CR146","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1152\/physiol.00016.2017","volume":"32","author":"S Sun","year":"2017","unstructured":"Sun S, Li H, Chen J, Qian Q (2017) Lactic acid: no longer an inert and end-product of glycolysis. Physiology 32:453\u2013463. https:\/\/doi.org\/10.1152\/physiol.00016.2017","journal-title":"Physiology"},{"key":"2_CR147","doi-asserted-by":"publisher","unstructured":"Suzuki A, Puri S, Leland P et al (2019) Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer. PLoS One 14:1\u201319. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0217131","DOI":"10.1371\/JOURNAL.PONE.0217131"},{"key":"2_CR148","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/S12672-025-02516-0","volume":"16","author":"J Tang","year":"2025","unstructured":"Tang J, Xiong W, Liu X et al (2025) Combination treatment with Phloretin enhances the anti-tumor efficacy of radiotherapy in lung cancer models. Discover Oncol 16:685. https:\/\/doi.org\/10.1007\/S12672-025-02516-0","journal-title":"Discover Oncol"},{"key":"2_CR149","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-019-1847-2","volume":"577","author":"A Tasdogan","year":"2020","unstructured":"Tasdogan A, Faubert B, Ramesh V et al (2020) Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature 577:115\u2013120. https:\/\/doi.org\/10.1038\/s41586-019-1847-2","journal-title":"Nature"},{"key":"2_CR150","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/S41581-022-00587-8","volume":"18","author":"CT Taylor","year":"2022","unstructured":"Taylor CT, Scholz CC (2022) The effect of HIF on metabolism and immunity. Nat Rev Nephrol 18:573\u2013587. https:\/\/doi.org\/10.1038\/S41581-022-00587-8","journal-title":"Nat Rev Nephrol"},{"key":"2_CR151","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP (2002) Epithelial\u2013mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442\u2013454. https:\/\/doi.org\/10.1038\/nrc822","journal-title":"Nat Rev Cancer"},{"key":"2_CR152","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/S41556-022-00925-9","volume":"24","author":"GE Thomas","year":"2022","unstructured":"Thomas GE, Egan G, Garc\u00eda-Prat L et al (2022) The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness. Nat Cell Biol 24:872\u2013884. https:\/\/doi.org\/10.1038\/S41556-022-00925-9","journal-title":"Nat Cell Biol"},{"key":"2_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12885-023-10999-9","volume":"23","author":"M Trajkovic-Arsic","year":"2023","unstructured":"Trajkovic-Arsic M, Subramani E (2023) Is metabolism the magic bullet for targeted cancer therapy? BMC Cancer 23:1\u20133. https:\/\/doi.org\/10.1186\/S12885-023-10999-9","journal-title":"BMC Cancer"},{"key":"2_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/S12943-024-02119-3","volume":"23","author":"M Tufail","year":"2024","unstructured":"Tufail M, Jiang C-H, Li N (2024) Altered metabolism in cancer: insights into energy pathways and therapeutic targets. Mol Cancer 23:203. https:\/\/doi.org\/10.1186\/S12943-024-02119-3","journal-title":"Mol Cancer"},{"key":"2_CR155","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/PATH.6066","volume":"260","author":"A Van der Vreken","year":"2023","unstructured":"Van der Vreken A, Oudaert I, Ates G et al (2023) Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis. J Pathol 260:112\u2013123. https:\/\/doi.org\/10.1002\/PATH.6066","journal-title":"J Pathol"},{"key":"2_CR156","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrd3504","volume":"10","author":"MG Vander Heiden","year":"2011","unstructured":"Vander Heiden MG (2011) Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov 10:671\u2013684. https:\/\/doi.org\/10.1038\/nrd3504","journal-title":"Nat Rev Drug Discov"},{"key":"2_CR157","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (1979) 324:1029\u20131033. https:\/\/doi.org\/10.1126\/science.1160809","journal-title":"Science (1979)"},{"key":"2_CR158","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2174\/0929867003375119","volume":"7","author":"D Vander Jagt","year":"2012","unstructured":"Vander Jagt D, Deck L, Royer R (2012) Gossypol prototype of inhibitors targeted to dinucleotide folds. Curr Med Chem 7:479\u2013498. https:\/\/doi.org\/10.2174\/0929867003375119","journal-title":"Curr Med Chem"},{"key":"2_CR159","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-10-2828","volume":"71","author":"F V\u00e9gran","year":"2011","unstructured":"V\u00e9gran F, Boidot R, Michiels C et al (2011) Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kB\/IL-8 pathway that drives tumor angiogenesis. Cancer Res 71:2550\u20132560. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2828","journal-title":"Cancer Res"},{"key":"2_CR160","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3233\/CBM-150514","volume":"15","author":"PJ Vlachostergios","year":"2015","unstructured":"Vlachostergios PJ, Oikonomou KG, Gibilaro E, Apergis G (2015) Elevated lactic acid is a negative prognostic factor in metastatic lung cancer. Cancer Biomarkers 15:725\u2013734. https:\/\/doi.org\/10.3233\/CBM-150514","journal-title":"Cancer Biomarkers"},{"key":"2_CR161","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.semradonc.2004.04.004","volume":"14","author":"S Walenta","year":"2004","unstructured":"Walenta S, Mueller-Klieser WF (2004) Lactate: Mirror and motor of tumor malignancy. Semin Radiat Oncol 14:267\u2013274. https:\/\/doi.org\/10.1016\/j.semradonc.2004.04.004","journal-title":"Semin Radiat Oncol"},{"key":"2_CR162","first-page":"409","volume":"150","author":"S Walenta","year":"1997","unstructured":"Walenta S, Salameh A, Lyng H et al (1997) Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 150:409\u2013415","journal-title":"Am J Pathol"},{"key":"2_CR163","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.2174\/0929867043364711","volume":"11","author":"S Walenta","year":"2012","unstructured":"Walenta S, Schroeder T, Mueller-Klieser W (2012) Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem 11:2195\u20132204. https:\/\/doi.org\/10.2174\/0929867043364711","journal-title":"Curr Med Chem"},{"key":"2_CR164","unstructured":"Walenta S, Wetterling M, Lehrke M et al (2000) High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60:916\u2013921"},{"key":"2_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0280-y","volume":"16","author":"H Wang","year":"2016","unstructured":"Wang H, Wang L, Zhang Y et al (2016) Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth. Cancer Cell Int 16:9. https:\/\/doi.org\/10.1186\/s12935-016-0280-y","journal-title":"Cancer Cell Int"},{"key":"2_CR166","doi-asserted-by":"publisher","unstructured":"Wang J, Liu Z, Xu Y et al (2022) Enterobacterial LPS-inducible LINC00152 is regulated by histone lactylation and promotes cancer cells invasion and migration. Front Cell Infect Microbiol 12:1\u201313. https:\/\/doi.org\/10.3389\/FCIMB.2022.913815\/PDF","DOI":"10.3389\/FCIMB.2022.913815\/PDF"},{"key":"2_CR167","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/BF01712130","volume":"2","author":"O Warburg","year":"1923","unstructured":"Warburg O, Minami S (1923) Versuche an \u00dcberlebendem Carcinomgewebe. Klin Wochenschr 2:776\u2013777. https:\/\/doi.org\/10.1007\/BF01712130","journal-title":"Klin Wochenschr"},{"key":"2_CR168","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27:5904\u20135912. https:\/\/doi.org\/10.1038\/onc.2008.271","journal-title":"Oncogene"},{"key":"2_CR169","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2174\/138161206775201901","volume":"12","author":"W Wick","year":"2005","unstructured":"Wick W, Naumann U, Weller M (2005) Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12:341\u2013349. https:\/\/doi.org\/10.2174\/138161206775201901","journal-title":"Curr Pharm Des"},{"key":"2_CR170","doi-asserted-by":"publisher","first-page":"e159839","DOI":"10.1172\/JCI159839","volume":"132","author":"EE Wicks","year":"2022","unstructured":"Wicks EE, Semenza GL (2022) Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest 132:e159839. https:\/\/doi.org\/10.1172\/JCI159839","journal-title":"J Clin Invest"},{"key":"2_CR171","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3390\/CANCERS15215297","volume":"15","author":"W Wiese","year":"2023","unstructured":"Wiese W, Barczuk J, Racinska O et al (2023) PI3K\/Akt\/mTOR signaling pathway in blood malignancies-new therapeutic possibilities. Cancers 15:5297. https:\/\/doi.org\/10.3390\/CANCERS15215297","journal-title":"Cancers"},{"key":"2_CR172","doi-asserted-by":"publisher","first-page":"27213","DOI":"10.1074\/jbc.M411950200","volume":"280","author":"MC Wilson","year":"2005","unstructured":"Wilson MC, Meredith D, Manning Fox JE et al (2005) Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is embigin (gp70). J Biol Chem 280:27213\u201327321. https:\/\/doi.org\/10.1074\/jbc.M411950200","journal-title":"J Biol Chem"},{"key":"2_CR173","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1158\/0008-5472.CAN-11-3881","volume":"72","author":"JW Wojtkowiak","year":"2012","unstructured":"Wojtkowiak JW, Rothberg JM, Kumar V et al (2012) Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 72:3938\u20133947. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3881","journal-title":"Cancer Res"},{"key":"2_CR174","doi-asserted-by":"publisher","unstructured":"Xie B, Lin J, Chen X et al (2023) CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol Cancer 22:1\u201318. https:\/\/doi.org\/10.1186\/S12943-023-01856-1","DOI":"10.1186\/S12943-023-01856-1"},{"key":"2_CR175","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2014.03.003","volume":"19","author":"H Xie","year":"2014","unstructured":"Xie H, Hanai JI, Ren JG et al (2014) Targeting lactate dehydrogenase-A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell Metab 19:795\u2013809. https:\/\/doi.org\/10.1016\/j.cmet.2014.03.003","journal-title":"Cell Metab"},{"key":"2_CR176","doi-asserted-by":"publisher","first-page":"165576","DOI":"10.1016\/j.bbadis.2019.165576","volume":"1866","author":"Q Xie","year":"2020","unstructured":"Xie Q, Zhu Z, He Y et al (2020) A lactate-induced Snail\/STAT3 pathway drives GPR81 expression in lung cancer cells. Biochim Biophys Acta, Mol Basis Dis 1866:165576. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165576","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"2_CR177","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.7150\/IJBS.73398","volume":"18","author":"J Yang","year":"2022","unstructured":"Yang J, Luo L, Zhao C et al (2022) A positive feedback loop between inactive VHL-triggered histone lactylation and PDGFR\u03b2 signaling drives clear cell renal cell carcinoma progression. Int J Biol Sci 18:3470. https:\/\/doi.org\/10.7150\/IJBS.73398","journal-title":"Int J Biol Sci"},{"key":"2_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40164-024-00482-X","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y (2024) Cancer metabolism and carcinogenesis. Exp Hematol Oncol 13:1\u201314. https:\/\/doi.org\/10.1186\/S40164-024-00482-X","journal-title":"Exp Hematol Oncol"},{"key":"2_CR179","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1007\/s00018-008-8224-x","volume":"65","author":"SJ Yeung","year":"2008","unstructured":"Yeung SJ, Pan J, Lee MH (2008) Roles of p53, MYC and HIF-1 in regulating glycolysis\u2014the seventh hallmark of cancer. Cell Mol Life Sci 65:3981\u20133999. https:\/\/doi.org\/10.1007\/s00018-008-8224-x","journal-title":"Cell Mol Life Sci"},{"key":"2_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13046-015-0221-Y","volume":"34","author":"GJ Yoshida","year":"2015","unstructured":"Yoshida GJ (2015) Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exper Clin Cancer Res 34:1\u201310. https:\/\/doi.org\/10.1186\/S13046-015-0221-Y","journal-title":"J Exper Clin Cancer Res"},{"key":"2_CR181","doi-asserted-by":"publisher","unstructured":"Yu J, Chai P, Xie M et al (2021) Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Biol 22:1\u201321. https:\/\/doi.org\/10.1186\/S13059-021-02308-Z","DOI":"10.1186\/S13059-021-02308-Z"},{"key":"2_CR182","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.7150\/JCA.21125","volume":"8","author":"L Yu","year":"2017","unstructured":"Yu L, Chen X, Sun X et al (2017) The glycolytic switch in tumors: how many players are involved?. J Cancer 8:3430\u20133440. https:\/\/doi.org\/10.7150\/JCA.21125","journal-title":"J Cancer"},{"key":"2_CR183","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0006-2952(01)00636-0","volume":"62","author":"Y Yu","year":"2001","unstructured":"Yu Y, Deck JA, Hunsaker LA et al (2001) Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4. Biochem Pharmacol 62:81\u201389. https:\/\/doi.org\/10.1016\/S0006-2952(01)00636-0","journal-title":"Biochem Pharmacol"},{"key":"2_CR184","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3349\/ymj.2016.57.6.1312","volume":"57","author":"S Yuan","year":"2016","unstructured":"Yuan S, Qiao T, Zhuang X et al (2016) Knockdown of the M2 isoform of pyruvate kinase (PKM2) with shRNA enhances the effect of docetaxel in human NSCLC cell lines in vitro. Yonsei Med J 57:1312\u20131323. https:\/\/doi.org\/10.3349\/ymj.2016.57.6.1312","journal-title":"Yonsei Med J"},{"key":"2_CR185","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.trecan.2017.09.002","volume":"3","author":"E Zacksenhaus","year":"2017","unstructured":"Zacksenhaus E, Shrestha M, Liu JC et al (2017) Mitochondrial OXPHOS induced by RB1 deficiency in breast cancer: implications for anabolic metabolism, stemness, and metastasis. Trends Cancer 3:768\u2013779. https:\/\/doi.org\/10.1016\/j.trecan.2017.09.002","journal-title":"Trends Cancer"},{"key":"2_CR186","doi-asserted-by":"publisher","first-page":"15947","DOI":"10.1074\/jbc.RA118.004180","volume":"293","author":"M \u017ddralevi\u0107","year":"2018","unstructured":"\u017ddralevi\u0107 M, Brand A, Ianni LDi et al (2018) Double genetic disruption of lactate dehydrogenases A and B is required to ablate the \u201cWarburg effect\u201d restricting tumor growth to oxidative metabolism. J Biol Chem 293:15947\u201315961. https:\/\/doi.org\/10.1074\/jbc.RA118.004180","journal-title":"J Biol Chem"},{"key":"2_CR187","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/S41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H et al (2019) Metabolic regulation of gene expression by histone lactylation. Nature 574:575\u2013580. https:\/\/doi.org\/10.1038\/S41586-019-1678-1","journal-title":"Nature"},{"key":"2_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S43556-020-00012-1","volume":"2","author":"H Zhao","year":"2021","unstructured":"Zhao H, Li Y (2021) Cancer metabolism and intervention therapy. Mol Biomed 2:1\u201327. https:\/\/doi.org\/10.1186\/S43556-020-00012-1","journal-title":"Mol Biomed"},{"key":"2_CR189","doi-asserted-by":"publisher","unstructured":"Zhao Y, Butler EB, Tan M (2013) Targeting cellular metabolism to improve cancer therapeutics. Cell\u00a0Death Dis 4:1\u201310. https:\/\/doi.org\/10.1038\/CDDIS.2013.60","DOI":"10.1038\/CDDIS.2013.60"},{"key":"2_CR190","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"J Zheng","year":"2012","unstructured":"Zheng J (2012) Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation. Oncol Lett 4:1151\u20131157","journal-title":"Oncol Lett"},{"key":"2_CR191","doi-asserted-by":"publisher","unstructured":"Zheng M, Wu C, Yang K et al (2021) Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis. Pharmacol Res 164:1\u201310. https:\/\/doi.org\/10.1016\/J.PHRS.2020.105367","DOI":"10.1016\/J.PHRS.2020.105367"},{"key":"2_CR192","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12951-017-0316-z","volume":"15","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Wen H, Gu L et al (2017) Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells. J Nanobiotechnol 15:87. https:\/\/doi.org\/10.1186\/s12951-017-0316-z","journal-title":"J Nanobiotechnol"},{"key":"2_CR193","doi-asserted-by":"publisher","first-page":"B179","DOI":"10.1158\/1535-7163.TARG-23-B179","volume":"22","author":"R Zielinski","year":"2023","unstructured":"Zielinski R, Castillo MM, Grybowski D et al (2023) Abstract B179: 2-deoxy-D-glucose (2-DG) combination with ketogenic diet induces sedation and hypothermia in mice that becomes lethal. Mol Cancer Ther 22:B179\u2013B179. https:\/\/doi.org\/10.1158\/1535-7163.TARG-23-B179","journal-title":"Mol Cancer Ther"},{"key":"2_CR194","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, Xie F, Wang S et al (2024) Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell 187:2375\u20132392.e33. https:\/\/doi.org\/10.1016\/j.cell.2024.04.002","journal-title":"Cell"}],"container-title":["Advances in Experimental Medicine and Biology","Cancer Metabolic Remodeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-12166-0_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:16:49Z","timestamp":1783768609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-12166-0_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032121653","9783032121660"],"references-count":194,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-12166-0_2","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-032-12166-0","asserted-by":"object"}]},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"12 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}